Creative Planning Adma Biologics, Inc. Transaction History
Creative Planning
- $103 Billion
- Q4 2024
A detailed history of Creative Planning transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Creative Planning holds 47,198 shares of ADMA stock, worth $929,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,198
Previous 54,947
14.1%
Holding current value
$929,800
Previous $1.1 Million
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
338Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$367 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$359 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$293 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$223 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$109 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.87B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...